A clinical study to evaluate the efficacy of manjistadi lepa in the management of superficial phlebitis

Clinical study to evaluate the efficacy of manjistadi lepa in the management of siragata vyadhi with special reference to superficial phlebitis - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/084369

Enrollment

Registered

2025-04-08

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I800- Phlebitis and thrombophlebitis ofsuperficial vessels of lower extremities

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Clinical signs and symptoms of Superficial phlebitis as a result of injury. 2.Established cases of Superficial phlebitis in varicose veins. 3.Established cases of Superficial phlebitis at the site of canula insertion. 4.Patients irrespective of all age group will be selected.

Exclusion criteria

Exclusion criteria: 1)Patients with immunocompromised status like Human Immunodeficiency Virus and Hepatitis B positive and Tuberculosis. 2)Patients with Deep Vein Thrombosis 3)Patients with uncontrolled hyperglycemia (HbA1c more than 8percentile)

Design outcomes

Primary

Measure	Time frame
EFFECTIVENESS OF MANJISTADI LEPA IN REDUCING THE SYMPTOMS OF SUPERFICIAL PHLEBITISTimepoint: 1 WEEK	—

Secondary

Measure	Time frame
EFFECTIVENESS OF MANJISTADI LEPA IN REDUCING THE SYMPTOMS OF SUPERFICIAL PHLEBITISTimepoint: 3 WEEKS	—

Countries

India

Contacts

Public ContactDr Prasanna Narasimha Rao

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan

profpnrao@sdmcahhassan.org9448064277

Outcome results